Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Gross margin
€ -14,470
▼ 108% vs 2024
Profit
Caution€ -408,349
▼ 190% vs 2024
Debts
Low€ 133,289
▼ 76% vs 2024
nuclivision from Gent, company number BE0786830643, closed financial year 2025 with a result of € -408,349 after tax. For that financial year nuclivision recorded a gross margin of € -14,470 and equity of € 1.9 million. Compared with financial year 2024, the result moved from € -140,654 to € -408,349. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.
What happened at nuclivision?
What happened at nuclivision in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 408,349. Source: NBB ↗
- Gabriel Paul Krestin became a director. NBB
- SUIIUS BV became a director. NBB
- Heran Partners BV became a director. NBB
- Maarten Larmuseau became a director. NBB
- Lumo Labs BV became a director. NBB
- Tomas Brants became a director. NBB
- New establishment in Gent. KBO
In short
From € 161,043 loss in 2023 to € 408,349 loss in 2025.
Paid € 3,631 in corporate taxes since 2023.
A new publication or filing at nuclivision? We notify you, reason included.
Follow nuclivisionNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind nuclivision are SUIIUS BV, Gabriel Paul Krestin, Heran Partners BV, Maarten Larmuseau, Lumo Labs BV and Tomas Brants. The same people are also behind Lynxcare Clinical Informatics, FOx Biosystems, ASPECT ANALYTICS, Heran HealthTech Fund I and ImmuneSpec.
Directors
According to the 2025 annual accounts
Director · represented by Vandenberk Kris
since 2025
Gabriel Paul Krestin
Director
since 2026
Director · represented by Verrelst Herman
Also active at: Lynxcare Clinical Informatics, FOx Biosystems, ASPECT ANALYTICS +5 more
since 2025
Maarten Larmuseau
Director
since 2025
Lumo Labs BV
Director · represented by Hannes Thomas
since 2025
Tomas Brants
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Edward Pynaertkaai 87
9000 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
Details
- Company number
- 0786.830.643
- VAT number
- BE 0786.830.643
- Registered office
- Edward Pynaertkaai 87, 9000 Gent
- Names & denominations
- nuclivision
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 3 June 2022
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Ontwerpen van computerprogramma’s
Ontwerpen en programmeren van computerprogramma's
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Activiteiten van medisch specialisten
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van medische laboratoria
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied